13F Insight

Doyle Janeen Noel

CIK: 0002069239•Chief Corp. & Bus. Dev. Ofcr
Officer
Primary company: Janux Therapeutics, Inc. (JANX)

Doyle Janeen Noel is a corporate insider (Chief Corp. & Bus. Dev. Ofcr) at Janux Therapeutics, Inc. (JANX) filing SEC Form 4 transactions. 3 transactions. Source: SEC EDGAR.

Total Transactions
3
Total Buy Value
$0
Total Sell Value
$0
Net Activity
$0
Last Transaction
Jun 2026
Companies
1

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Sale
Shares
4,059
Price
$14.03
Value
$57K
Type
Award
Shares
154,000
Price
-
Value
-
Type
Award
Shares
44,000
Price
-
Value
-